AI

Ziv Ofek, cofounder and CEO of MDClone, discusses how GenAI tools may soon make it easier for clinicians to analyze synthetic data themselves if guardrails are in place to ensure that the AI's conclusions are correct.  

CasePointer's workforce will join Deloitte, and the company will use the business's software in conjunction with its GovConnect assets to assist its government clients.

Dr. Michal Tzuchman Katz, cofounder and CEO of Kahun, discusses how educating doctors on the source of information for the company's clinical knowledge graph and how the product supports patient care encourage its adoption.  

A study published in Clinical Imaging says ChatGPT can simplify radiology reports, but the results differ significantly based on racial context.

The South Korean company now plans to expand the application of its AI to diagnose other medical conditions, including heart and neurological disorders. 

Dr. Tim O'Connell, cofounder and CEO of Emtelligent, believes healthcare organizations should not rely solely on AI for business processes and must train models on data sets that represent "all of humanity."  

The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.

Also, Lunit has completed its acquisition of breast screening AI company Volpara.

CIO Craig Kwiatkowski offers a look at the AI tools deployed at the famous health system and discusses the measure of success of AI initiatives, as well as how the technology can help identify disparities in care access and outcomes.  

Cedars-Sinai CIO Craig Kwiatkowski discusses using the FAVES approach (fair, appropriate, valid, effective and safe) in genAI adoption, as well as the "build vs buy" question, and challenges with integrating AI technologies into existing systems.